Ionis Pharmaceuticals
Develops antisense medicines through owned launches and pharmaceutical partnerships.
$61.05
After-hours close+0.01 (+0.02%)
At close$61.04(−2.23%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.22 | — | — |
| Jul 2026 | −$1.08 | −$0.69 | +36.1% |
| Apr 2026 | −$0.85 | −$0.56 | +34.1% |
| Feb 2026 | −$1.24 | −$1.41 | −14.0% |
| Oct 2025 | −$1.15 | −$0.61 | +47.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$1.22 | — | — | $181.8M | — | — |
| Jul 29, 2026 | −$1.08 | −$0.69 | +36.1% | $189.1M | $268.0M | +41.7% |
| Apr 29, 2026 | −$0.85 | −$0.56 | +34.1% | $195.6M | $246.0M | +25.8% |
| Feb 25, 2026 | −$1.24 | −$1.41 | −14.0% | $156.1M | $203.0M | +30.1% |
| Oct 29, 2025 | −$1.15 | −$0.61 | +47.0% | $153.6M | $156.7M | +2.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 30, 2025 | ||||||
| Apr 30, 2025 | ||||||
| Feb 19, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 21, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 3, 2023 | ||||||
| Feb 22, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 4, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 5, 2021 | ||||||
| Feb 24, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 6, 2020 | ||||||
| Feb 26, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 9, 2019 | ||||||
| Feb 27, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 4, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 9, 2017 | ||||||
| Feb 28, 2017 | ||||||
| Nov 9, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 4, 2016 | ||||||
| Feb 25, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Aug 4, 2015 | ||||||